Delivery Order SPE2DB22D3004-SPE2DB24FPF43
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $1,861.92 Firm Fixed Price Delivery Order, is for the supply of 4,567,896,829 units of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. The contract has an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,110.44, is for the delivery of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,302.02 delivery order is for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml containers. The contract has a firm fixed price and an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,780.23, is for the delivery of Cephalexin 250 mg/5 ml suspension in 100 ml containers. This is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award is for the delivery of Cephalexin 250 mg/5 ml suspension in 100 ml bottles to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $1,663.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,460.70, is for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml quantities. The contract has a July 12, 2024 completion date and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,725.49 firm fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of September 27, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,489.91, is a delivery order for 4,562,888,391 units of Cephalexin 250 mg capsules. The contract has an ultimate completion date of November 24, 2023 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,300.51 firm fixed-price delivery order is for the supply of 4564427862 Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $24,585.28 and has an ultimate completion date of October 20, 2023. The contract is for the supply of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPF43Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,306.98, is for the delivery of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. The contract is a firm fixed-price delivery order with a period of performance ending on February 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award appears to be a specific delivery order against that larger IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 2/6/24 |